Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 68% by 2024.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Sales forecast by analysts have been recently revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● With an expected P/E ratio at 55.55 and 44.54 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.